Patents by Inventor modeRNA Therapeutics

modeRNA Therapeutics has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130203115
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using thereof.
    Type: Application
    Filed: January 11, 2013
    Publication date: August 8, 2013
    Applicant: MODERNA THERAPEUTICS, INC.
    Inventor: MODERNA THERAPEUTICS, INC.
  • Publication number: 20130165504
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules for their use in improving organ viability and/or longevity.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 27, 2013
    Applicant: modeRNA Therapeutics
    Inventor: modeRNA Therapeutics
  • Publication number: 20130156849
    Abstract: The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity.
    Type: Application
    Filed: December 14, 2012
    Publication date: June 20, 2013
    Applicant: modeRNA THERAPEUTICS
    Inventor: MODERNA THERAPEUTICS
  • Publication number: 20130123481
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: January 17, 2013
    Publication date: May 16, 2013
    Applicant: MODERNA THERAPEUTICS
    Inventor: modeRNA Therapeutics
  • Publication number: 20130115272
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: October 3, 2012
    Publication date: May 9, 2013
    Applicant: modeRNA Therapeutics
    Inventor: modeRNA Therapeutics